Platelet Activating Factor Contributes to Vascular Leak in Acute Dengue Infection

Background Although plasma leakage is the hallmark of severe dengue infections, the factors that cause increased vascular permeability have not been identified. As platelet activating factor (PAF) is associated with an increase in vascular permeability in other diseases, we set out to investigate its role in acute dengue infection. Materials and Methods PAF levels were initially assessed in 25 patients with acute dengue infection to determine if they were increased in acute dengue. For investigation of the kinetics of PAF, serial PAF values were assessed in 36 patients. The effect of dengue serum on tight junction protein ZO-1 was determined by using human endothelial cell lines (HUVECs). The effect of dengue serum on and trans-endothelial resistance (TEER) was also measured on HUVECs. Results PAF levels were significantly higher in patients with acute dengue (n = 25; p = 0.001) when compared to healthy individuals (n = 12). In further investigation of the kinetics of PAF in serial blood samples of patients (n = 36), PAF levels rose just before the onset of the critical phase. PAF levels were significantly higher in patients with evidence of vascular leak throughout the course of the illness when compared to those with milder disease. Serum from patients with dengue significantly down-regulated expression of tight junction protein, ZO-1 (p = 0.004), HUVECs. This was significantly inhibited (p = 0.004) by use of a PAF receptor (PAFR) blocker. Serum from dengue patients also significantly reduced TEER and this reduction was also significantly (p = 0.02) inhibited by prior incubation with the PAFR blocker. Conclusion Our results suggest the PAF is likely to be playing a significant role in inducing vascular leak in acute dengue infection which offers a potential target for therapeutic intervention.

[1]  G. Zimmerman,et al.  The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis , 2002, Critical care medicine.

[2]  S. Kalayanarooj,et al.  Virus-Induced Decline in Soluble Vascular Endothelial Growth Receptor 2 Is Associated with Plasma Leakage in Dengue Hemorrhagic Fever , 2006, Journal of Virology.

[3]  A. Issekutz,et al.  Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes , 1997, Journal of virology.

[4]  Shamala Devi Sekaran,et al.  Cytokine factors present in dengue patient sera induces alterations of junctional proteins in human endothelial cells. , 2012, The American journal of tropical medicine and hygiene.

[5]  S. Opal,et al.  Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. , 1996, The New England journal of medicine.

[6]  S. Halstead,et al.  Pathologic highlights of dengue hemorrhagic fever in 13 autopsy cases from Myanmar. , 2014, Human pathology.

[7]  Fernando A Bozza,et al.  Platelet Activation and Apoptosis Modulate Monocyte Inflammatory Responses in Dengue , 2014, The Journal of Immunology.

[8]  C. S. Lee,et al.  A higher production of platelet activating factor in ex vivo heterologously secondary dengue-2 virus infections. , 1995, Acta microbiologica et immunologica Hungarica.

[9]  S. Sekaran,et al.  Cytokine Expression Profile of Dengue Patients at Different Phases of Illness , 2012, PloS one.

[10]  Fernando A Bozza,et al.  Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity , 2008, BMC infectious diseases.

[11]  A. Osterhaus,et al.  Microbial Translocation Is Associated with Extensive Immune Activation in Dengue Virus Infected Patients with Severe Disease , 2013, PLoS neglected tropical diseases.

[12]  Albert D. M. E. Osterhaus,et al.  Dengue Virus Pathogenesis: an Integrated View , 2009, Clinical Microbiology Reviews.

[13]  S. Yoksan,et al.  Alteration of Cytokines and Chemokines During Febrile Episodes Associated With Endothelial Cell Damage and Plasma Leakage in Dengue Hemorrhagic Fever , 2012, The Pediatric infectious disease journal.

[14]  B. Smart.  Platelet-Activating Factor, PAF Acetylhydrolase, and Severe Anaphylaxis , 2008, Pediatrics.

[15]  F. Bozza,et al.  Emerging concepts in dengue pathogenesis: interplay between plasmablasts, platelets, and complement in triggering vasculopathy. , 2014, Critical Reviews in Immunology.

[16]  L. Epstein,et al.  Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1-beta, tumor necrosis factor, or IFN-gamma. , 1988, Journal of immunology.

[17]  P. MacAry,et al.  Dengue: Challenges for Policy Makers and Vaccine Developers , 2014, Current Infectious Disease Reports.

[18]  G. Liss,et al.  Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis. , 2008, The Journal of allergy and clinical immunology.

[19]  F. Snyder.  Platelet-Activating Factor and Related Lipid Mediators , 1987, Springer US.

[20]  Cameron P. Simmons,et al.  Current concepts: Dengue , 2012 .

[21]  M. Perretti,et al.  Sphingosine-1-Phosphate Modulates Vascular Permeability and Cell Recruitment in Acute Inflammation In Vivo , 2011, Journal of Pharmacology and Experimental Therapeutics.

[22]  Stephen J. Thomas,et al.  Critical issues in dengue vaccine development , 2011, Current opinion in infectious diseases.

[23]  S. Im,et al.  Involvement of nuclear factor-kappa B in platelet-activating factor-mediated tumor necrosis factor-alpha expression. , 1997, European journal of immunology.

[24]  J. Sugatani,et al.  Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. , 1988, The Journal of clinical investigation.

[25]  M. Teixeira,et al.  Immunopathology and Infectious Diseases Platelet-Activating Factor Receptor Is Essential for the Development of Experimental Cerebral Malaria , 2011 .

[26]  John S. Brownstein,et al.  The global distribution and burden of dengue , 2013, Nature.

[27]  E. Undurraga,et al.  Economic and Disease Burden of Dengue in Southeast Asia , 2013, PLoS neglected tropical diseases.

[28]  N. M. Dung,et al.  Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. , 1999, The American journal of tropical medicine and hygiene.

[29]  M. Wilson,et al.  Platelet-activating factor mediates pulmonary macromolecular leak following intestinal ischemia-reperfusion. , 1996, Journal of Surgical Research.

[30]  Mauro M. Teixeira,et al.  Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection , 2009, Proceedings of the National Academy of Sciences.

[31]  P. Devine,et al.  Evaluation of a Commercial Capture Enzyme-Linked Immunosorbent Assay for Detection of Immunoglobulin M and G Antibodies Produced during Dengue Infection , 1998, Clinical Diagnostic Laboratory Immunology.

[32]  S. Im,et al.  Involvement of nuclear factor‐xB in platelet‐activating factor‐mediated tumor necrosis factor‐α expression , 1997 .

[33]  T. Singer,et al.  A real-time impedance-based screening assay for drug-induced vascular leakage. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[34]  J. Chu,et al.  Dengue Virus Infection Mediates HMGB1 Release from Monocytes Involving PCAF Acetylase Complex and Induces Vascular Leakage in Endothelial Cells , 2012, PloS one.

[35]  I. Choi,et al.  Molecular Mechanisms for Lipopolysaccharide-induced Biphasic Activation of Nuclear Factor-κB (NF-κB)* , 2002, The Journal of Biological Chemistry.

[36]  E. Martin,et al.  Role of Platelet-Activating Factor in Leukocyte-Independent Plasma Extravasation and Mast Cell Activation during Endotoxemia☆ , 2000 .

[37]  J. Spitzer,et al.  Platelet activating factor stimulates and primes the liver, Kupffer cells and neutrophils to release superoxide anion. , 1992, Free radical research communications.